Teva And Celltrion Gain Arthritis Advantage On Rituximab

Truxima Biosimilar Now Available In Rheumatoid Arthritis Indication In US

 
• By Akriti Seth and David Wallace
  
Watch_Face_Advantage
Teva is aiming to take advantage of its exclusive indication for its rituximab biosimilar • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products